This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2002 May;176(3):194-7.

doi: 10.1136/ewjm.176.3.194.

Why were the benefits of tPA exaggerated?

Griffin Trotter¹

Affiliations

Affiliation

¹ St Louis University, Center for Health Care Ethics and Emergency Medicine, Division Salus Center (Health Sciences), 3545 Lafayette Ave, MO 63104, USA. trotterc@slu.edu

PMID: 12016246
PMCID: PMC1071715
DOI: 10.1136/ewjm.176.3.194

Why were the benefits of tPA exaggerated?

Griffin Trotter. West J Med. 2002 May.

. 2002 May;176(3):194-7.

doi: 10.1136/ewjm.176.3.194.

Author

Griffin Trotter¹

Affiliation

¹ St Louis University, Center for Health Care Ethics and Emergency Medicine, Division Salus Center (Health Sciences), 3545 Lafayette Ave, MO 63104, USA. trotterc@slu.edu

PMID: 12016246
PMCID: PMC1071715
DOI: 10.1136/ewjm.176.3.194

No abstract available

PubMed Disclaimer

Figures

Figure 1
Does this education campaign show protreatment bias?

See this image and copyright information in PMC

Similar articles

Tissue plasminogen activator (tPA) for acute ischaemic stroke: why so much has been made of so little.
Hoffman JR. Hoffman JR. Med J Aust. 2003 Oct 6;179(7):333-4. doi: 10.5694/j.1326-5377.2003.tb05584.x. Med J Aust. 2003. PMID: 14503891 No abstract available.
Testing new ideas: is a picture worth a thousand words?
Yealy DM, Callaham ML. Yealy DM, et al. Ann Emerg Med. 2009 Sep;54(3):337-8. doi: 10.1016/j.annemergmed.2009.07.015. Ann Emerg Med. 2009. PMID: 19695416 No abstract available.
Why are stroke patients excluded from tPA therapy? An analysis of patient eligibility.
Fink JN, Selim MH, Kumar S, Schlaug G. Fink JN, et al. Neurology. 2001 Nov 13;57(9):1739-40. doi: 10.1212/wnl.57.9.1739. Neurology. 2001. PMID: 11706134 No abstract available.
Thrombolytics for hyperacute stroke in children.
Amlie-Lefond C, Fullerton HJ. Amlie-Lefond C, et al. Pediatr Hematol Oncol. 2009 Apr-May;26(3):103-7. doi: 10.1080/08880010902773230. Pediatr Hematol Oncol. 2009. PMID: 19382031 Review.
Low-dose tissue plasminogen activator and standard-dose tissue plasminogen activator in acute ischemic stroke in Asian populations: a review.
Ramaiah SS, Yan B. Ramaiah SS, et al. Cerebrovasc Dis. 2013;36(3):161-6. doi: 10.1159/000354162. Epub 2013 Oct 12. Cerebrovasc Dis. 2013. PMID: 24135524 Review.

See all similar articles

Cited by

Thrombolysis in acute ischaemic stroke: a guide to patient selection.
Lindley RI. Lindley RI. CNS Drugs. 2005;19(6):539-51. doi: 10.2165/00023210-200519060-00005. CNS Drugs. 2005. PMID: 15963002 Review.
Fifty Years of Acute Ischemic Stroke Treatment: A Personal History.
Grotta JC. Grotta JC. Cerebrovasc Dis. 2021;50(6):666-680. doi: 10.1159/000519843. Epub 2021 Oct 14. Cerebrovasc Dis. 2021. PMID: 34649237 Free PMC article. Review.
A user's guide to the NINDS rt-PA stroke trial database.
Dachs RJ, Burton JH, Joslin J. Dachs RJ, et al. PLoS Med. 2008 May 20;5(5):e113. doi: 10.1371/journal.pmed.0050113. PLoS Med. 2008. PMID: 18494557 Free PMC article.
Thrombolysis for acute ischaemic stroke.
Wardlaw JM, Murray V, Berge E, del Zoppo GJ. Wardlaw JM, et al. Cochrane Database Syst Rev. 2014 Jul 29;2014(7):CD000213. doi: 10.1002/14651858.CD000213.pub3. Cochrane Database Syst Rev. 2014. PMID: 25072528 Free PMC article.

References

1. Schrof JM. Stroke busters: new treatments in the fight against“brain attacks.” US News World Rep 1999. March 15;126:62-64, 68. - PubMed
1. von Kummer R, Allen KL, Holle R, et al. Acute stroke: usefulness ofearly CT findings before thrombolytic therapy.Radiology 1997;205:327-333. - PubMed
1. Camarata PJ, Heros RC, Latchaw RE. “Brainattack”—the rationale for treating stroke as a medical emergency.Neurosurgery 1994;34:144-157. - PubMed
1. Alberts MJ. Hyperacute stroke therapy with tissue plasminogenactivator. Am J Cardiol 1997;80:29D-34D. - PubMed
1. Hachinski V. Thrombolysis in stroke: between the promise and theperil [editorial]. JAMA 1996;276:995-996. - PubMed

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Europe PubMed Central
- PubMed Central